Skip to main content

Vir Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14 at 3:45 p.m. PT in San Francisco, California.

A live webcast of the presentation will be made available under Events & Presentations in the Investors section of the Vir Biotechnology website and will be archived for 30 days.

About Vir Biotechnology

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a portfolio of preclinical programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology routinely posts information that may be important to investors on its website.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.30
+1.74 (0.83%)
AAPL  273.88
+1.74 (0.64%)
AMD  211.31
-2.53 (-1.18%)
BAC  51.63
+1.23 (2.43%)
GOOG  311.18
+0.26 (0.08%)
META  651.92
+12.62 (1.97%)
MSFT  398.23
+9.23 (2.37%)
NVDA  197.16
+4.31 (2.24%)
ORCL  149.56
+3.42 (2.34%)
TSLA  415.91
+6.53 (1.60%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.